Findings

What do systematic reviews say?

42 questions · 42 findings · 1 reviews

No studies found 18 · 42.9%GRADE not reported 0 · 0%Very low 0 · 0%Low 6 · 14.3%Moderate 11 · 26.2%High 7 · 16.7%

Serious adverse events · people with chronic gout

Febuxostat 120 mg/day showed no clear difference in serious Adverse Events compared with allopurinol (high certainty).

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
RR 1.2 [0.7, 1.93]
3 studies · 1041 participants
High

Withdrawals due to adverse events · people with chronic gout

Febuxostat 120 mg/day showed no clear difference in discontinuations due to adverse events compared with allopurinol (high certainty).

1 finding from 1 review

Febuxostat for treating chronic gout 2012 · Cochrane Headline outcomes only
RR 1.6 [0.49, 5]
3 studies · 1041 participants
High